m |
|||
Line 12: | Line 12: | ||
<center><img src="https://static.igem.org/mediawiki/2016/thumb/5/58/T--Alverno_CA--Alverno_iGEM_2016_Logo.png/600px-T--Alverno_CA--Alverno_iGEM_2016_Logo.png" alt="Alverno iGEM Logo" style="width:300px;"></center> | <center><img src="https://static.igem.org/mediawiki/2016/thumb/5/58/T--Alverno_CA--Alverno_iGEM_2016_Logo.png/600px-T--Alverno_CA--Alverno_iGEM_2016_Logo.png" alt="Alverno iGEM Logo" style="width:300px;"></center> | ||
<div class="column full_size incomplete judges-will-not-evaluate"> | <div class="column full_size incomplete judges-will-not-evaluate"> | ||
− | |||
− | |||
− | + | We have contributed in vitro characterization of plasmids WM16_035, WM16_036, and WM16_044 - WM16_049 (sfGFP reporters containing insulating RBS parts B0034, B0031, B0029, B0064, B0030, B0035, B0032, and B0033, respectively). See our collaborations page for more details. | |
+ | |||
</div> | </div> |
Revision as of 03:15, 15 October 2016
We have contributed in vitro characterization of plasmids WM16_035, WM16_036, and WM16_044 - WM16_049 (sfGFP reporters containing insulating RBS parts B0034, B0031, B0029, B0064, B0030, B0035, B0032, and B0033, respectively). See our collaborations page for more details.